125 related articles for article (PubMed ID: 23911286)
21. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
[TBL] [Abstract][Full Text] [Related]
22. TGIF2 interacts with histone deacetylase 1 and represses transcription.
Melhuish TA; Gallo CM; Wotton D
J Biol Chem; 2001 Aug; 276(34):32109-14. PubMed ID: 11427533
[TBL] [Abstract][Full Text] [Related]
23. PHRF1 Promotes Cell Invasion by Modulating SOX4 Expression in Colorectal Cancer HCT116-p53
Lin HW; Shih TW; Amanna A; Chang MS
Anticancer Res; 2023 Dec; 43(12):5437-5446. PubMed ID: 38030167
[TBL] [Abstract][Full Text] [Related]
24. Regulation of TG-interacting factor by transforming growth factor-beta.
Chen F; Ogawa K; Nagarajan RP; Zhang M; Kuang C; Chen Y
Biochem J; 2003 Apr; 371(Pt 2):257-63. PubMed ID: 12593671
[TBL] [Abstract][Full Text] [Related]
25. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.
Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K
Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202
[TBL] [Abstract][Full Text] [Related]
26. The Smad transcriptional corepressor TGIF recruits mSin3.
Wotton D; Knoepfler PS; Laherty CD; Eisenman RN; Massagué J
Cell Growth Differ; 2001 Sep; 12(9):457-63. PubMed ID: 11571228
[TBL] [Abstract][Full Text] [Related]
27. PHRF1 promotes the class switch recombination of IgA in CH12F3-2A cells.
Lee JY; Chou NL; Yu YR; Shih HA; Lin HW; Lee CK; Chang MS
PLoS One; 2023; 18(8):e0285159. PubMed ID: 37540725
[TBL] [Abstract][Full Text] [Related]
28. Drosophila TGIF proteins are transcriptional activators.
Hyman CA; Bartholin L; Newfeld SJ; Wotton D
Mol Cell Biol; 2003 Dec; 23(24):9262-74. PubMed ID: 14645536
[TBL] [Abstract][Full Text] [Related]
29. Cytoplasmic PML: from molecular regulation to biological functions.
Jin G; Gao Y; Lin HK
J Cell Biochem; 2014 May; 115(5):812-8. PubMed ID: 24288198
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
31. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
Chen Y; Wright J; Meng X; Leppard KN
Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
[TBL] [Abstract][Full Text] [Related]
32. Modulation of M2-type pyruvate kinase activity by the cytoplasmic PML tumor suppressor protein.
Shimada N; Shinagawa T; Ishii S
Genes Cells; 2008 Mar; 13(3):245-54. PubMed ID: 18298799
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer.
Buczek ME; Miles AK; Green W; Johnson C; Boocock DJ; Pockley AG; Rees RC; Hulman G; van Schalkwyk G; Parkinson R; Hulman J; Powe DG; Regad T
Oncogene; 2016 Jun; 35(26):3465-75. PubMed ID: 26549027
[TBL] [Abstract][Full Text] [Related]
34. Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program.
Vasilaki E; Morikawa M; Koinuma D; Mizutani A; Hirano Y; Ehata S; Sundqvist A; Kawasaki N; Cedervall J; Olsson AK; Aburatani H; Moustakas A; Miyazono K; Heldin CH
Sci Signal; 2016 Aug; 9(442):ra84. PubMed ID: 27555661
[TBL] [Abstract][Full Text] [Related]
35. Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts.
Xu WX; Liu SZ; Wu D; Qiao GF; Yan J
Cell Physiol Biochem; 2015; 37(4):1581-91. PubMed ID: 26517826
[TBL] [Abstract][Full Text] [Related]
36. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.
Kuo HY; Huang YS; Tseng CH; Chen YC; Chang YW; Shih HM; Wu CW
Cell Cycle; 2014; 13(19):3132-42. PubMed ID: 25486572
[TBL] [Abstract][Full Text] [Related]
37. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
38. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
Carbone R; Botrugno OA; Ronzoni S; Insinga A; Di Croce L; Pelicci PG; Minucci S
Mol Cell Biol; 2006 Feb; 26(4):1288-96. PubMed ID: 16449642
[TBL] [Abstract][Full Text] [Related]
39. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.
Légaré S; Cavallone L; Mamo A; Chabot C; Sirois I; Magliocco A; Klimowicz A; Tonin PN; Buchanan M; Keilty D; Hassan S; Laperrière D; Mader S; Aleynikova O; Basik M
Cancer Res; 2015 Oct; 75(20):4351-63. PubMed ID: 26297734
[TBL] [Abstract][Full Text] [Related]
40. OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis.
Wu RS; Hong JJ; Wu JF; Yan S; Wu D; Liu N; Liu QF; Wu QW; Xie YY; Liu YJ; Zheng ZZ; Chan EC; Zhang ZM; Li BA
Oncotarget; 2017 Jun; 8(24):39401-39416. PubMed ID: 28455959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]